FDA Inspection 1029066 — South Florida Institute for Reproductive Medicine

South Florida Institute for Reproductive Medicine — FEI 3007787718

The FDA completed an inspection of South Florida Institute for Reproductive Medicine on August 7, 2017 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 7, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Naples, FL (United States)